‘We want to de-risk the CRISPR-Cas9 patent minefield’, says Sigma-Aldrich IP licensing boss

‘We want to de-risk the CRISPR-Cas9 patent minefield’, says Sigma-Aldrich IP licensing boss

IAM speaks exclusively to Christopher Arnot about the crowded CRISPR IP landscape

Unlock unlimited access to all IAM content